Peter Agnes

Peter Agnes currently serves as Group Head of Portfolio Finance and Operating Partner in Life Sciences at B-FLEXION, leading efforts across investment affiliates and portfolio companies in capital markets, strategy, finance, and M&A. Since 2025, Peter has held board positions at Naveris, Inc., Radius Health, Inc., and Boston Pharmaceuticals, where responsibilities included executing a notable M&A process resulting in a $2 billion sale to GSK. Additional board roles at Corium Innovations, Corium, and advisory functions at Will Ventures highlight Peter's extensive involvement in strategic finance and capital formation. Previous experience includes serving as Chief Operating Officer at Gurnet Point Capital, focusing on fund operations and management. Peter's academic qualifications include a BA in Government from Dartmouth College and an MBA from Duke University's Fuqua School of Business.